
SD BioSensor, Inc
137310.KS
₩6,070
Updated: 24/09/2026, 05:13:41
Market Cap
₩726.09B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
KR
Stock valuation chart
One-year closing share-price history for 137310.KS
Company Profile
SD Biosensor Inc is an in vitro diagnostic company. It is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The company researches and develops products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products.
KRW
KSC
CEO: Hyo Keun Lee
Employees: 656
Asset Summaries
Latest generated summaries for 137310.KS
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for 137310.KS.
- Share price
- ₩6,070
- Market cap
- ₩726.09B
- Exchange
- KSC
- Currency
- KRW
- CEO
- Hyo Keun Lee
- Employees
- 656
- IPO date
- 16/07/2021
- Beta
- 0.71
- Last dividend
- ₩0
- Day range
- ₩6,030 – ₩6,150
- 52-week range
- ₩5,800 – ₩10,870
- 1-day performance
- -0.65%
- 1-year performance
- 4.66%
- Current drawdown (1Y)
- -44.16%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- KR7137310009
- Created
- 07/09/2026, 05:16:41
- Last update
- 24/09/2026, 05:13:41
Track SD BioSensor, Inc with an AI analyst
See which prediction-market events move 137310.KS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to 137310.KS from your Railway `news_articles` table.
No news found for this symbol.